Novo Nordisk
NDC labeler code: 0169
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Insulin aspartNovolog, Novolog Mix 70/30, Fiasp · 10 products
- SomatropinNorditropin, Omnitrope · 4 products
- ConcizumabAlhemo · 3 products
- Somapacitan-becoSogroya · 3 products
- NedosiranRivfloza · 3 products
- Insulin degludecTresiba · 3 products
- DasiglucagonZegalogue · 2 products
- LiraglutideVictoza, Saxenda · 1 product
- WaterSterile Water, Bacteriostatic Water, Insulin Diluting Medium for Kirsty · 1 product
- Insulin degludec and liraglutideXultophy 100/3.6 · 1 product
- Macimorelin acetateMacrilen · 1 product
- EstradiolEstradiol Vaginal, Dotti, Estradiol Transdermal System · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| December 20, 2024 | BLA761315 | Concizumab ALHEMO | Novo Nordisk Inc |
| September 29, 2023 | NDA215842 | Nedosiran RIVFLOZA | Novo |
| March 22, 2021 | NDA214231 | Dasiglucagon ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR) | Zealand Pharma |
| August 28, 2020 | BLA761156 | Somapacitan-beco SOGROYA | Novo Nordisk Inc |
| December 20, 2017 | NDA205598 | Macimorelin acetate MACRILEN | Aeterna Zentaris |
| September 29, 2017 | BLA208751 | Insulin aspart FIASP, FIASP FLEXTOUCH, FIASP PENFILL | Novo |
| November 21, 2016 | BLA208583 | Insulin degludec and liraglutide XULTOPHY 100/3.6 | Novo |
| September 25, 2015 | BLA203314 | Insulin degludec TRESIBA | Novo |
| January 25, 2010 | NDA022341 | Liraglutide VICTOZA | Novo Nordisk Inc |
| June 20, 2000 | BLA021148 | Somatropin NORDITROPIN, NORDITROPIN FLEXPRO, NORDITROPIN NORDIFLEX | Novo Nordisk Inc |
| June 7, 2000 | BLA020986 | Insulin aspart, Water NOVOLOG, NOVOLOG FLEXPEN, NOVOLOG FLEXTOUCH | Novo Nordisk Inc |
| March 26, 1999 | NDA020908 | Estradiol VAGIFEM | Novo Nordisk Inc |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026